Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

This study has been completed.

Study NCT00006136 Information provided by Office of Rare Diseases (ORD)

First Received: August 3, 2000 Last Updated: November 4, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given